Comorbidities and Patient Outcomes in Carbapenem-Resistant Gram-negative Bacterial Infections

Authors

• Jean-Francois Jabbour
• Yixuan Li
• Angelique E Boutzoukas
• Blake Hanson
• Yohei Doi
• Eric Cober
• Erica Herc, Henry Ford HealthFollow
• Lauren Komarow
• Jose M Munita
• Martin E Stryjewski
• Cesar A Arias
• David L Paterson
• Michael J Satlin
• Vance G Fowler
• Robert A Bonomo
• David van Duin

Recommended Citation

Jabbour JF, Li Y, Boutzoukas AE, Hanson B, Doi Y, Cober E, Herc E, Komarow L, Munita JM, Stryjewski ME, Arias CA, Paterson DL, Satlin MJ, Fowler VG, Jr., Bonomo RA, van Duin D. Comorbidities and Patient Outcomes in Carbapenem-Resistant Gram-Negative Bacterial Infections. Open Forum Infect Dis. 2026;13(9):551.

Document Type

Article

Publication Date

9-1-2026

Publication Title

Open Forum Infect Dis

Abstract

In an international cohort of hospitalized patients included in the Multi-Drug-Resistant Organism Network with carbapenem-resistant Gram-negative infections, increased age-adjusted Charlson Comorbidity Index scores were associated with increased mortality particularly in those with respiratory and less so in those with bloodstream infections. Cirrhosis, diabetes, and peripheral vascular disease were important contributors.

PubMed ID

42746212

Volume

13

Issue

9

First Page

551

Last Page

551